Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells-Reference-Cited by-同舟云学术

Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells

Published:1985-02-15 Issue:4 Volume:55 Page:713-720
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Livingston Philip O.,Albino Anthony P.,Chung Tae June C.,Real Francisco X.,Houghton Alan N.,Oettgen Herbert F.,Old Lloyd J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

2. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

3. Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics.

4. , , , , . Cell surface antigens of human cancer. In: ed. Biological Markers of Neoplasia: Basic and Applied Aspects. New York: Elsevier/North Holland, 1978; 73–90.

5. Antibody-dependent cell-mediated cytotoxicity for cultured autologous melanoma cells

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering Non-Human RNA Viruses for Cancer Therapy;Vaccines;2023-10-20

2. Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine;Molecular Therapy;2012-09

3. Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma;Cancer;2010-08-02

4. Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses;Current Cancer Drug Targets;2007-03-01

5. Enhanced immune responses induced by vaccine using Sendai virosomes as carrier;International Journal of Pharmaceutics;2007-02